Search

Your search keyword '"Lecour, S"' showing total 188 results

Search Constraints

Start Over You searched for: Author "Lecour, S" Remove constraint Author: "Lecour, S"
188 results on '"Lecour, S"'

Search Results

152. HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity.

153. Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.

154. Loss of cardioprotection with ischemic preconditioning in aging hearts: role of sirtuin 1?

155. Trials, tribulations and speculation! Report from the 7th Biennial Hatter Cardiovascular Institute Workshop.

156. Different lipid profiles according to ethnicity in the Heart of Soweto study cohort of de novo presentations of heart disease.

157. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection.

158. Lowering the alcohol content of red wine does not alter its cardioprotective properties.

159. High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: Role of STAT3 as part of the SAFE pathway.

160. Influence of tumour necrosis factor alpha on the outcome of ischaemic postconditioning in the presence of obesity and diabetes.

162. Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection.

163. Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin.

164. Effects of sphingosine-1-phosphate on acute contractile heart failure (ACHF).

165. Ethanolamine is a novel STAT-3 dependent cardioprotective agent.

166. Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations.

167. TNFα protects cardiac mitochondria independently of its cell surface receptors.

168. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway.

169. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?

171. Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion.

172. TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning.

173. TNFalpha-induced cytoprotection requires the production of free radicals within mitochondria in C2C12 myotubes.

174. Ceramide-induced preconditioning involves reactive oxygen species.

175. Ceramide attenuates hypoxic cell death via reactive oxygen species signaling.

176. Free radicals trigger TNF alpha-induced cardioprotection.

177. Direct demonstration of nitric oxide formation in organs of rabbits treated by transdermal glyceryl trinitrate using an in vivo spin trapping technique.

178. [Sphingolipid signaling: a potential pathway for TNF-alpha induced preconditioning].

179. Evidence for the extrapulmonary localization of inhaled nitric oxide.

180. Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program.

181. Intrarenal detection of nitric oxide using electron spin resonance spectroscopy in hypertensive lipopolysaccharide-treated rats.

182. Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection.

183. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass.

184. Levels of nitric oxide in the heart after experimental myocardial ischemia.

185. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients.

186. Electron spin resonance detection of nitric oxide generation in major organs from LPS-treated rats.

187. Demonstration of the production of oxygen-centered free radicals during electrolysis using E.S.R. spin-trapping techniques: effects on cardiac function in the isolated rat heart.

188. In vitro studies of interactions of NO. donor drugs with superoxide and hydroxyl radicals.

Catalog

Books, media, physical & digital resources